Clinical Trial Update: Immunoglobulin Dosage and Administration Form in CIDP and MMN

View source ↗

Summary

A completed clinical trial update from Rigshospitalet evaluating immunoglobulin dosage and administration form for CIDP and MMN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy
• Multifocal Motor Neuropathy

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy | Status: COMPLETED